227 related articles for article (PubMed ID: 15612963)
1. BAL eotaxin and IL-5 in asthma, and the effects of inhaled corticosteroid and beta2 agonist.
Feltis BN; Reid DW; Ward C; Walters EH
Respirology; 2004 Nov; 9(4):507-13. PubMed ID: 15612963
[TBL] [Abstract][Full Text] [Related]
2. Airway cell and cytokine changes in early asthma deterioration after inhaled corticosteroid reduction.
Khor YH; Feltis BN; Reid DW; Ward C; Johns DP; Wood-Baker R; Walters EH
Clin Exp Allergy; 2007 Aug; 37(8):1189-98. PubMed ID: 17651149
[TBL] [Abstract][Full Text] [Related]
3. Asthmatics able to step down from inhaled corticosteroid treatment without loss of asthma control have low serum eotaxin/CCL11.
Hoffmann HJ; Nielsen LP; Harving H; Heinig JH; Dahl R
Clin Respir J; 2008 Jul; 2(3):149-57. PubMed ID: 20298323
[TBL] [Abstract][Full Text] [Related]
4. Smoking affects eotaxin levels in asthma patients.
Krisiukeniene A; Babusyte A; Stravinskaite K; Lotvall J; Sakalauskas R; Sitkauskiene B
J Asthma; 2009 Jun; 46(5):470-6. PubMed ID: 19544167
[TBL] [Abstract][Full Text] [Related]
5. Exhaled breath condensate levels of eotaxin and macrophage-derived chemokine in stable adult asthma patients.
Ko FW; Lau CY; Leung TF; Wong GW; Lam CW; Lai CK; Hui DS
Clin Exp Allergy; 2006 Jan; 36(1):44-51. PubMed ID: 16393265
[TBL] [Abstract][Full Text] [Related]
6. Changes in serum eotaxin and eosinophil cationic protein levels, and eosinophil count during treatment of childhood asthma.
Chu YT; Chiang W; Wang TN; Hung CH; Jong YJ; Wu JR
J Microbiol Immunol Infect; 2007 Apr; 40(2):162-7. PubMed ID: 17446966
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
Xu J; Jiang F; Nayeri F; Zetterström O
Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
[TBL] [Abstract][Full Text] [Related]
8. Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol.
Jarjour NN; Wilson SJ; Koenig SM; Laviolette M; Moore WC; Davis WB; Doherty DE; Hamid Q; Israel E; Kavuru MS; Ramsdell JW; Tashkin DP; Reilly DS; Yancey SW; Edwards LD; Stauffer JL; Dorinsky PM; Djukanovic R
J Allergy Clin Immunol; 2006 Jul; 118(1):44-52. PubMed ID: 16815137
[TBL] [Abstract][Full Text] [Related]
9. Induced sputum and bronchoalveolar lavage as tools for evaluating the effects of inhaled corticosteroids in patients with asthma.
Nocker RE; Out TA; Weller FR; de Riemer MJ; Jansen HM; van der Zee JS
J Lab Clin Med; 2000 Jul; 136(1):39-49. PubMed ID: 10882226
[TBL] [Abstract][Full Text] [Related]
10. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma.
Masoli M; Weatherall M; Holt S; Beasley R
Thorax; 2005 Sep; 60(9):730-4. PubMed ID: 16135679
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation.
Lamkhioued B; Renzi PM; Abi-Younes S; Garcia-Zepada EA; Allakhverdi Z; Ghaffar O; Rothenberg MD; Luster AD; Hamid Q
J Immunol; 1997 Nov; 159(9):4593-601. PubMed ID: 9379061
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
Gibson PG; Powell H; Ducharme FM
J Allergy Clin Immunol; 2007 Feb; 119(2):344-50. PubMed ID: 17291852
[TBL] [Abstract][Full Text] [Related]
13. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ
COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
[TBL] [Abstract][Full Text] [Related]
14. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
Delea TE; Hagiwara M; Stanford RH; Stempel DA
Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
[TBL] [Abstract][Full Text] [Related]
15. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
Rowe BH; Wong E; Blitz S; Diner B; Mackey D; Ross S; Senthilselvan A
Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245
[TBL] [Abstract][Full Text] [Related]
16. Increased vascular permeability precedes cellular inflammation as asthma control deteriorates.
Khor YH; Teoh AK; Lam SM; Mo DC; Weston S; Reid DW; Walters EH
Clin Exp Allergy; 2009 Nov; 39(11):1659-67. PubMed ID: 19860817
[TBL] [Abstract][Full Text] [Related]
17. Persistent airway T-lymphocyte activation in chronic corticosteroid-treated symptomatic asthma.
Redington AE; Wilson JW; Walls AF; Madden J; Djukanovic R; Holgate ST; Howarth PH
Ann Allergy Asthma Immunol; 2000 Dec; 85(6 Pt 1):501-7. PubMed ID: 11152173
[TBL] [Abstract][Full Text] [Related]
18. Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: improved clinical efficacy and dosing options in patients with asthma.
Ankerst J
J Asthma; 2005 Nov; 42(9):715-24. PubMed ID: 16316864
[TBL] [Abstract][Full Text] [Related]
19. Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils.
Koopmans JG; Lutter R; Jansen HM; van der Zee JS
J Allergy Clin Immunol; 2005 Nov; 116(5):1007-13. PubMed ID: 16275368
[TBL] [Abstract][Full Text] [Related]
20. Safety of long-acting beta2-agonists in the treatment of asthma.
Cazzola M; Matera MG
Ther Adv Respir Dis; 2007 Oct; 1(1):35-46. PubMed ID: 19124346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
